Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 57


Changes in the preferences of US physicians-in-training for medical interventions throughout medical education.

Valentino MA, Chervoneva I, Diemer GA.

Med Educ. 2016 Feb;50(2):214-24. doi: 10.1111/medu.12938.


Prevalence, Risk Factors, and Correlates of Anxiety at 1 Year After Moderate to Severe Traumatic Brain Injury.

Hart T, Fann JR, Chervoneva I, Juengst SB, Rosenthal JA, Krellman JW, Dreer LE, Kroenke K.

Arch Phys Med Rehabil. 2015 Dec 18. pii: S0003-9993(15)01495-1. doi: 10.1016/j.apmr.2015.08.436. [Epub ahead of print]


ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas.

Capparelli C, Rosenbaum S, Berman-Booty LD, Salhi A, Gaborit N, Zhan T, Chervoneva I, Roszik J, Woodman SE, Davies MA, Setiady YY, Osman I, Yarden Y, Aplin AE.

Cancer Res. 2015 Sep 1;75(17):3554-67. doi: 10.1158/0008-5472.CAN-14-2959. Epub 2015 Jul 23.


Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases.

Valsecchi ME, Terai M, Eschelman DJ, Gonsalves CF, Chervoneva I, Shields JA, Shields CL, Yamamoto A, Sullivan KL, Laudadio M, Berd D, Mastrangelo MJ, Sato T.

J Vasc Interv Radiol. 2015 Apr;26(4):523-32.e2. doi: 10.1016/j.jvir.2014.11.037. Epub 2015 Feb 9.


A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA.

Lin J, Zhan T, Duffy D, Hoffman-Censits J, Kilpatrick D, Trabulsi EJ, Lallas CD, Chervoneva I, Limentani K, Kennedy B, Kessler S, Gomella L, Antonarakis ES, Carducci MA, Force T, Kelly WK.

Am J Cancer Ther Pharmacol. 2014 Sep 7;2(1):21-32.


A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease.

Grosso D, Gaballa S, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Martinez-Outschoorn U, Wagner JL, O'Hara W, Rudolph S, Chervoneva I, Colombe B, Farley PC, Flomenberg P, Pro B, Sharma M, Shi W, Weiss M, Flomenberg N.

Biol Blood Marrow Transplant. 2015 Apr;21(4):646-52. doi: 10.1016/j.bbmt.2014.12.019. Epub 2014 Dec 23.


Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment.

Yang N, Liu C, Peck AR, Girondo MA, Yanac AF, Tran TH, Utama FE, Tanaka T, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Rui H.

Breast Cancer Res. 2013;15(5):R73.


Metabolic syndrome increases risk for pulmonary embolism after hip and knee arthroplasty.

Mraovic B, Hipszer BR, Epstein RH, Parvizi J, Pequignot EC, Chervoneva I, Joseph JI.

Croat Med J. 2013 Aug;54(4):355-61.


Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.

Sato T, Tran TH, Peck AR, Girondo MA, Liu C, Goodman CR, Neilson LM, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Fuchs SY, Rui H.

Oncogene. 2014 Apr 24;33(17):2215-24. doi: 10.1038/onc.2013.172. Epub 2013 May 27.


Analyzing the ingredients of a telephone counseling intervention for traumatic brain injury.

Hart T, Brockway JA, Whyte J, Bell KR, Neuberger S, Chervoneva I.

Disabil Rehabil. 2013 Sep;35(19):1668-75. doi: 10.3109/09638288.2012.751131. Epub 2013 Jan 22.


Two-stage hierarchical modeling for analysis of subpopulations in conditional distributions.

Chervoneva I, Zhan T, Iglewicz B, Hauck WW, Birk DE.

J Appl Stat. 2012;39(2):445-460. Epub 2011 Dec 16.


Conversion from enzyme-inducing antiepileptic drugs to topiramate: effects on lipids and C-reactive protein.

Mintzer S, Skidmore CT, Rankin SJ, Chervoneva I, Pequinot E, Capuzzi DM, Sperling MR.

Epilepsy Res. 2012 Jan;98(1):88-93. doi: 10.1016/j.eplepsyres.2011.10.001. Epub 2011 Nov 25.


Major and minor depression after traumatic brain injury.

Hart T, Brenner L, Clark AN, Bogner JA, Novack TA, Chervoneva I, Nakase-Richardson R, Arango-Lasprilla JC.

Arch Phys Med Rehabil. 2011 Aug;92(8):1211-9. doi: 10.1016/j.apmr.2011.03.005. Erratum in: Arch Phys Med Rehabil. 2011 Dec;92(12):2098.


Constrained S-estimators for linear mixed effects models with covariance components.

Chervoneva I, Vishnyakov M.

Stat Med. 2011 Jun 30;30(14):1735-50. doi: 10.1002/sim.4169. Epub 2011 Jan 13.


The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma.

Showalter TN, Zhan T, Anne PR, Chervoneva I, Mitchell EP, Yeo CJ, Rosato EL, Kennedy EP, Berger AC.

J Gastrointest Surg. 2011 Aug;15(8):1411-6. doi: 10.1007/s11605-011-1518-6. Epub 2011 Apr 27.


Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine.

Mahipal A, Terai M, Berd D, Chervoneva I, Patel K, Mastrangelo MJ, Sato T.

Cancer Immunol Immunother. 2011 Jul;60(7):1039-45. doi: 10.1007/s00262-011-1019-1. Epub 2011 Apr 26.


Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone.

Holmes P, Lloyd J, Chervoneva I, Pequinot E, Cornfield DB, Schwartz GF, Allen KG, Palazzo JP.

Cancer. 2011 Aug 15;117(16):3650-7. doi: 10.1002/cncr.25942. Epub 2011 Feb 11.


Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma.

Behling KC, Tang A, Freydin B, Chervoneva I, Kadakia S, Schwartz GF, Rui H, Witkiewicz AK.

Breast Cancer Res Treat. 2011 Oct;129(3):717-24. doi: 10.1007/s10549-010-1254-8. Epub 2010 Nov 19.


Latency to first seizure after temporal lobectomy predicts long-term outcome.

Buckingham SE, Chervoneva I, Sharan A, Zangaladze A, Mintzer S, Skidmore C, Nei M, Evans J, Pequignot E, Sperling MR.

Epilepsia. 2010 Oct;51(10):1987-93.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk